An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

You may be eligible if

• 1. Received at least 1 dose of treatment with vonsetamig in study R5459-RT-1944 \[NCT05092347\].
• 2. Received after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944
• 3. Willing and able to comply with clinic visits and study-related procedures
• 4. Provide informed consent signed by study patient or legally acceptable representative